Xconomy: Alexion News, Articles and Opinions

“alexion” Archives

Entry	Author	Date	Location
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More	Alex Lash	06/28/19	National
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M	Sarah de Crescenzo	02/06/19	San Diego
For San Antonio’s Consideration: A Biotech Incubator and Accelerator	David Holley	04/08/16	Texas
Cubist Maintains Growth Streak, As Investors Fear Generic Threat, Thin Pipeline	Ryan McBride	01/25/10	Boston
Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy on Demand

We offer a number of ways to subscribe for free!